Daniel Gedeon Teper, CEO, 10% Owner at IMMUNE PHARMACEUTICALS INC (IMNP), bought 40,700 shares at $1.23 ($50K) on 2015-10-05, disclosed to the SEC on 2015-10-05.
Scheduled purchase ($50k) by CEO, 10% Owner under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| IMNP | BUY | 2016-01-19 | $25K | — | Filing → |
| IMNP | BUY | 2016-01-12 | $24K | — | Filing → |
| IMNP | BUY | 2016-01-06 | $50K | — | Filing → |